title: High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum.
authors: Tufts Medical Center, Boston, MA, USA.
authors: Jacqueline E
authors: JE
authors: Greb
authors: Tufts Medical Center, Boston, MA, USA.
authors: Alice B
authors: AB
authors: Gottlieb
authors: Tufts Medical Center, Boston, MA, USA.
authors: Ari M
authors: AM
authors: Goldminz
mesh_terms: D003879:Dermatologic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D000069549:Ustekinumab / Q000008:administration & dosage*
chemical_list: D003879:Dermatologic Agents; D000069549:Ustekinumab